Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation

被引:172
作者
Grabcanovic-Musija, Fikreta [1 ]
Obermayer, Astrid [2 ]
Stoiber, Walter [2 ]
Krautgartner, Wolf-Dietrich [2 ]
Steinbacher, Peter [2 ]
Winterberg, Nicole [3 ]
Bathke, Cornelius [3 ]
Klappacher, Michaela [2 ]
Studnicka, Michael [1 ]
机构
[1] Paracelsus Med Univ, Univ Clin Pneumol, A-5020 Salzburg, Austria
[2] Salzburg Univ, Dept Cell Biol, Biomed Ultrastruct Res Grp, A-5020 Salzburg, Austria
[3] Salzburg Univ, Dept Math, A-5020 Salzburg, Austria
关键词
COPD; Induced sputum; Neutrophils; Neutrophil extracellular traps; OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; ALVEOLAR MACROPHAGES; INNATE IMMUNITY; LUNG-CANCER; NETOSIS; MYELOPEROXIDASE; INFLAMMATION; ACTIVATION; MECHANISMS;
D O I
10.1186/s12931-015-0221-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: COPD is a progressive disease of the airways that is characterized by neutrophilic inflammation, a condition known to promote the excessive formation of neutrophil extracellular traps (NETs). The presence of large amounts of NETs has recently been demonstrated for a variety of inflammatory lung diseases including cystic fibrosis, asthma and exacerbated COPD. Objective: We test whether excessive NET generation is restricted to exacerbation of COPD or whether it also occurs during stable periods of the disease, and whether NET presence and amount correlates with the severity of airflow limitation. Patients, materials and methods: Sputum samples from four study groups were examined: COPD patients during acute exacerbation, patients with stable disease, and smoking and non-smoking controls without airflow limitation. Sputum induction followed the ECLIPSE protocol. Confocal laser microscopy (CLSM) and electron microscopy were used to analyse samples. Immunolabelling and fluorescent DNA staining were applied to trace NETs and related marker proteins. CLSM specimens served for quantitative evaluation. Results: Sputum of COPD patients is clearly characterised by NETs and NET-forming neutrophils. The presence of large amounts of NET is associated with disease severity (p < 0.001): over 90 % in exacerbated COPD, 45 % in stable COPD, and 25 % in smoking controls, but less than 5 % in non-smokers. Quantification of NET-covered areas in sputum preparations confirms these results. Conclusions: NET formation is not confined to exacerbation but also present in stable COPD and correlates with the severity of airflow limitation. We infer that NETs are a major contributor to chronic inflammatory and lung tissue damage in COPD.
引用
收藏
页数:12
相关论文
共 68 条
[1]   Probabilistic index: an intuitive non-parametric approach to measuring the size of treatment effects [J].
Acion, L ;
Peterson, JJ ;
Temple, S ;
Arndt, S .
STATISTICS IN MEDICINE, 2006, 25 (04) :591-602
[2]   IgA Enhances NETosis and Release of Neutrophil Extracellular Traps by Polymorphonuclear Cells via Fcα Receptor I [J].
Aleyd, Esil ;
van Hout, Miel W. M. ;
Ganzevles, Sonja H. ;
Hoeben, Kees A. ;
Everts, Vincent ;
Bakema, Jantine E. ;
van Egmond, Marjolein .
JOURNAL OF IMMUNOLOGY, 2014, 192 (05) :2374-2383
[3]  
[Anonymous], NPMV NONPARAMETRIC C
[4]  
[Anonymous], 2013, R LANG ENV STAT COMP
[5]   Neutrophilic infiltration within the airway smooth muscle in patients with COPD [J].
Baraldo, S ;
Turato, G ;
Badin, C ;
Bazzan, E ;
Beghé, B ;
Zuin, R ;
Calabrese, F ;
Casoni, G ;
Maestrelli, P ;
Papi, A ;
Fabbri, LM ;
Saetta, M .
THORAX, 2004, 59 (04) :308-312
[6]   Frontrunners in novel pharmacotherapy of COPD [J].
Barnes, Peter J. .
CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (03) :300-307
[7]   Inhaled Corticosteroids in COPD: A Controversy [J].
Barnes, Peter J. .
RESPIRATION, 2010, 80 (02) :89-95
[8]   How to compare small multivariate samples using nonparametric tests [J].
Bathke, Arne C. ;
Harrar, Solomon W. ;
Madden, Laurence V. .
COMPUTATIONAL STATISTICS & DATA ANALYSIS, 2008, 52 (11) :4951-4965
[9]  
Boorsma Martin, 2007, COPD, V4, P321, DOI 10.1080/15412550701597720
[10]   Neutrophil extracellular traps kill bacteria [J].
Brinkmann, V ;
Reichard, U ;
Goosmann, C ;
Fauler, B ;
Uhlemann, Y ;
Weiss, DS ;
Weinrauch, Y ;
Zychlinsky, A .
SCIENCE, 2004, 303 (5663) :1532-1535